SLU-PP-915 dosage and reconstitution
Not yet. The pill-form successor to SLU-PP-332, tested only in mice, with no dose we can stand behind. For the idea itself, use 332.
Taken by mouth.
No human or useful animal protocol exists, so there is no basis for a cycle length or a break.
Staying safe
Things people sometimes notice
- Unknown; no one has given it to people in a study
- Users of SLU-PP-332 report a lower resting pulse and feeling warm, which may or may not carry over
- No published human or toxicology data of any kind
Stop and get help if (trouble breathing or swelling: call 911)
- Chest discomfort, palpitations, or an unusually slow or fast pulse
- Any new symptom you cannot explain, since nobody knows what to expect
- Signs of an allergic reaction
Talk to your doctor first, especially if
- You have any heart condition; ERR activation changes how heart muscle uses fuel and that is untested in people
- You take any daily prescription medicine, because the interaction profile is completely unknown
- You have liver disease, since nobody knows how the body clears it
- You are pregnant, nursing or trying to be
Mixing it
SLU-PP-915 is a small molecule taken orally, not a water-reconstituted peptide. There is no standard, validated preparation or dose, so anything below is approximate and community-sourced. Follow the vendor's handling guidance and treat the whole thing as research-grade.
Bring the product to room temperature.
Follow the vendor's handling and suspension instructions, as this is a small molecule, not a water-soluble peptide.
Measure carefully; there is no validated human protocol.
Store cool and out of light.
Keep any trial short given the complete lack of safety data.